Revolutionary Fuel-Free Energy System TAP Offers Nations Path to Energy Independence
DUBAI, DUBAI, UNITED ARAB EMIRATES, August 13, 2025 / EINPresswire.com / -- NEO7even Holdings announces the availability of TAP (Total Autonomous Power), a groundbreaking energy generation system that operates without fuel, sun, or wind. The technology uses calibrated magnetic resonance and kinetic motion to produce continuous electricity, potentially transforming how nations approach energy infrastructure.
TAP fundamentally changes the economics of energy by eliminating fuel costs and supply chain dependencies. The technology transforms energy from a variable market product into a fixed sovereign asset, offering nations unprecedented control over their power generation capabilities.
The system employs a proprietary combination of rare earth magnets, including Neodymium and Samarium-Cobalt, magnetized under vacuum conditions to create sustained oscillation. This motion drives generators that produce stable power output suitable for both small-scale and infrastructure-level deployment.
Unlike traditional renewable energy sources, TAP operates independently of weather conditions and requires no external fuel source. The technology offers two models: TAP.1 for household and microgrid applications, and TAP.2, a pendulum system designed for large-scale sovereign deployments.
Independent validation is ongoing through collaborations with universities and scientific institutions. The company reports successful real-world applications powering off-grid structures for sustained periods.
NEO7even Holdings operates through a licensing model rather than electricity sales, positioning TAP as a platform for governments to operate their own energy ecosystems with full control, zero fuel, and minimal maintenance.
The technology targets emerging markets where energy access remains a barrier to economic development, education, and healthcare delivery.
About NEO7even Holdings
NEO7even Holdings is a deep-tech innovation company focused on developing sovereign technology solutions for global infrastructure challenges. The company specializes in fuel-free energy systems and operates through a licensing model that enables nations to maintain full control over their energy infrastructure.
Matthias Siems
NEO7even
email us here
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
'Remarkable' €50m transfer could be the unexpected highlight of Chelsea's summer
The most explosive news of last weekend came from nowhere when it was revealed by top sources like Fabrizio Romano that Joao Felix was going to Saudi Arabia to join Al Nassr for a huge fee. Until then there had been very little interest in Felix. His old team Benfica seemed to be the only ones interested, and they were ready to sit tight and low-ball us until the deadline. Then from nowhere, the Saudis came in with a huge bid. 'Remarkable' bid saves Chelsea's bacon in disaster transfer Joao Felix watches from the sidelines. (Photo by) They discussed this on the London is Blue podcast, trying to make sense of it all. 'He's going to Saudi Arabia. The immediate fee is going to be €30m with a heavy sell on clause and add ons… Chelsea feel they have a guaranteed fee of €50m minimum for Joao Felix,' Dan Dormer said. But as they also pointed out, the fact that it ended well for us doesn't mean it wasn't a mistake to bring Felix back in the first place: 'It's remarkable business. It's a move that had to be done for Chelsea. He obviously was not going to play for the club again. It was a terrible transfer, and it has now kind of been remedied,' was co-presenter Nick Verlaney's take. You can see their discussion in the clip embedded here: Felix affair feels like it's full of secrets This whole Felix affair has something fishy about it – from the loan that finished a year before we signed him, to the relation to the Conor Gallagher to Atletico Madrid sale, to the bizarrely large fee we're getting for him from Al Nassr. It feels like there's more going on than meets the eye – we just hope we get to find out more, one day.
Yahoo
3 hours ago
- Yahoo
Nasus Pharma Announces Closing of Initial Public Offering
TEL AVIV, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) ('Nasus Pharma' or the 'Company'), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical conditions, today announced the closing of its initial public offering of 1,250,000 ordinary shares ('Ordinary Shares') at a public offering price of $8.00 per Ordinary Share. The gross proceeds of the offering were $10 million, prior to deducting underwriting discounts, commissions, and other offering expenses. Nasus Pharma's shares began trading on the NYSE American LLC exchange on August 13, 2025 under the ticker symbol 'NSRX'. Nasus Pharma has granted the underwriters an option for a period of up to 45 days from the date of the final prospectus, to purchase up to an additional 187,500 Ordinary Shares at the initial public offering price, less the underwriting discounts and commissions. The Company intends to use the net proceeds from the initial public offering for furthering the development of its intranasal Epinephrine program, including, manufacturing scale-up and additional Phase 2 studies, and the remainder for general and administrative corporate purposes, including working capital, and capital expenditures. Laidlaw & Company (UK) Ltd. and Craft Capital Management LLC acted as Joint Bookrunners for the offering. A registration statement on Form F-1 (File No. 333-288582) (the 'Registration Statement') relating to the initial public offering was filed with the Securities and Exchange Commission ('SEC') and declared effective by the SEC on August 12, 2025. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any securities referred to herein nor shall there be any sale of such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. The offering was made only by means of a prospectus forming a part of the Registration Statement. A copy of the final prospectus relating to this offering has been filed with the SEC and copies of the final prospectus can be obtained by contacting Laidlaw & Company (UK) Ltd., 521 Fifth Ave, 12th Floor, New York, NY 10075, or by calling 212-953-4900 or by e-mailing syndicate@ About Nasus Pharma Nasus Pharma is a clinical-stage pharmaceutical company developing a number of intranasal powder products addressing acute medical conditions in the community. NS002, Nasus's intranasal powder Epinephrine product candidate is being developed as a needle-free alternative to Epinephrine autoinjectors for patients with anaphylaxis. Intranasal administration is most suitable for those situations in which rapid drug delivery is required and offers needle free, easy to use alternatives. Nasus proprietary powder-based intranasal ('PBI') technology is designed for rapid and reliable drug delivery, leveraging the nasal cavity's rich vascular network for quick absorption. The PBI formulation uses uniform spherical powder particles for broad dispersion and potentially faster, higher absorption compared to liquid-based nasal products. Forward Looking Statements This press release contains 'forward-looking statements' that are subject to substantial risks and uncertainties. All statements, other than statements of historical fact, contained in this press release are forward-looking statements, including, among other things: statements related to the expected use of proceeds from the Company's initial public offering. Forward-looking statements contained in this press release may be identified by the use of words such as 'anticipate,' 'believe,' 'contemplate,' 'could,' 'estimate,' 'expect,' 'intend,' 'seek,' 'may,' 'might,' 'plan,' 'potential,' 'predict,' 'project,' 'target,' 'aim,' 'should,' "will' 'would,' or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on the Company's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. These and other risks and uncertainties are described more fully in the section titled 'Risk Factors' in the final prospectus related to the initial public offering filed with the SEC. Forward-looking statements contained in this announcement are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law. Contactinfo@ Pharma Ltd. Israelhttps:// Investor ContactMike MoyerLifeSci Advisors+1-617-308-4306mmoyer@
Yahoo
4 hours ago
- Yahoo
Warren Warns Crypto Regulation ‘Supercharges President Trump's Corruption'
Senator Elizabeth Warren (D-MA) warned Sunday that recently passed crypto legislation "supercharges President Trump's corruption," alleging his family's crypto business benefits from billions in foreign backing. Warren also accused the crypto industry of writing its own regulatory framework, while speaking on MSNBC's Morning Joe. "We need regulation that limits the corruption and the ability of elected officials to trade in it, that also limits the ability to blow up the economy with crypto,' Warren said. The Senator targeted both the recently passed GENIUS Act and the pending CLARITY Act, saying that crypto industry lobbying has reached new levels. Warren has shown continued resistance to both bills, particularly given President Trump's extensive financial ties to the sector through his family's World Liberty Financial venture. The Senator said the current rules are 'weak, weak restrictions' that leave the door open to abuse, and enable use by 'terrorists and drug traffickers.' She noted that the U.S. must implement regulations that 'limit corruption,' ensure consumer protection, cut off illicit finance, and that the crypto industry should not be allowed to 'write its own legislation.' "Crypto regulation in the U.S. is still at a very early stage, and Senator Warren's concerns about corruption, systemic risk, and illicit use are valid," Zakhil Suresh, CEO of crypto asset manager BitSave, told Decrypt. "The recently passed CLARITY Act in the House is a step in the right direction, but it needs to be shaped with input from a broad set of stakeholders, not just the crypto industry,' he added. Crypto legislation concerns Warren has repeatedly labeled Trump's involvement in USD1 as 'shady,' pointing to the stablecoin's rise after a $2 billion UAE-backed deal and warning that new laws could directly benefit him. Recently, Warren compared current crypto legislation to the Commodity Futures Modernization Act of 2000, which left derivatives largely unregulated and contributed to the 2008 financial crisis. Elizabeth Warren: American People Will 'Pay the Price' for GENIUS Act Trump ally Senator John Kennedy has also questioned whether the crypto industry should be allowed to draft its own rules, warning against insufficient oversight and comparing it to letting the internet "correct their own rules." Nitesh Mishra, co-founder & CTO at hedging platform ChaiDEX, told Decrypt that current U.S. crypto regulations "often fall short on issues like corruption, illicit use, and consumer protection." Mishra noted the U.S. dominates global crypto infrastructure while pursuing a re-dollarization strategy, but alleged Trump appears to "manipulate market liquidity for tactical gains" rather than pursue comprehensive regulation. Calling it ironic, he said crypto, 'once intended to counter banking–government collusion,' could now entrench established institutions, with muddled reforms 'stifling genuine retail innovation.' Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
